STOCK PURCHASE AGREEMENTStock Purchase Agreement • August 7th, 2018 • Ionis Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
This Stock Purchase Agreement (“Agreement”) is entered into as of April 19, 2018 (the “Execution Date”), by and between Biogen MA Inc., a Massachusetts corporation (“Biogen”), and Ionis Pharmaceuticals, Inc., a Delaware corporation (“Ionis”).
New Strategic Neurology Drug Discovery and Development Collaboration, Option and License Agreement Between Ionis Pharmaceuticals, Inc. And Biogen MA Inc.New Strategic Neurology Drug Discovery and Development Collaboration, Option and License Agreement • August 7th, 2018 • Ionis Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
This NEW STRATEGIC NEUROLOGY DRUG DISCOVERY AND DEVELOPMENT COLLABORATION, OPTION AND LICENSE AGREEMENT (the “Agreement”) is entered into as of the 19th day of April, 2018 (the “Execution Date”) by and between Ionis Pharmaceuticals, Inc., a Delaware corporation, having its principal place of business at 2855 Gazelle Court, Carlsbad, CA 92010 (“Ionis”), and Biogen MA Inc., a Massachusetts corporation, having its principal place of business at 225 Binney Street, Cambridge, MA 02142 (“Biogen”). Biogen and Ionis each may be referred to herein individually as a “Party” or collectively as the “Parties.” Capitalized terms used in this Agreement, whether used in the singular or the plural, have the meaning set forth in Appendix 1. All attached appendices and schedules are a part of this Agreement.
